22.1 C
New York
Monday, July 22, 2024
HomeIndia NewsIndia's Bharat Biotech offers Brazil potential COVID-19 vaccine

India’s Bharat Biotech offers Brazil potential COVID-19 vaccine


Related stories

Controversial godman comments on Hathras tragedy: “Fate cannot be challenged”

An Indian preacher, Bhole Baba, stated that the deaths...

Six killed in Oman mosque shooting, including Pakistanis and Indian

Six people, including four Pakistanis and one Indian, were...

India probe finds Apple policies harm developers

India’s antitrust body, the Competition Commission of India (CCI),...

Scores dead as Northeast India floods subside, wildlife threatened

The devastating floods in India’s northeastern regions have receded,...

Five soldiers killed in Kashmir militant attack

Indian troops in Jammu and Kashmir continued their search...

India’s Bharat Biotech this week offered Brazil a COVID-19 vaccine that is in late-stage clinical trials and a possible technology transfer partnership, a company executive said on Friday.

The private pharmaceutical company based in the southern city of Hyderabad is developing a whole-virion inactivated vaccine called Covaxin that could be licensed by the second quarter of 2021.
“The data looks really good in terms of reduction and also prevention of disease, and we started our Phase 3 clinical trials this week,” Executive Director Sai Prasad told Reuters.
Bharat Biotech is currently recruiting 26,000 volunteers in India for the trials and the results are expected between March and April, he said.
Pfizer Inc said on Wednesday it had offered to provide Brazil with millions of doses of its COVID-19 vaccine in the first half of 2021, amid evidence the coronavirus is spreading more rapidly in South America’s largest country.
Pfizer and German partner BioNTech SE reported final trial results that showed the vaccine was 95% effective in preventing COVID-19.
Bharat Biotech representatives met this week with Brazilian health ministry and regulatory agency officials to see what the requirements are for licensing the vaccine in Brazil and whether trials would have to be done there too.
“We are definitely open for partnerships and for technology transfers,” Prasad said in an interview from Hyderabad.
Bharat Biotech has sold a Hepatitis B vaccine to Brazil and is developing others for Zika and Chicungunya that the South American country is interested in, he said.


- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories